As the global health community grapples with the increasing prevalence of leukemia, the need for effective treatments has never been more critical. In 2023 alone, approximately 0.58 million cases of leukemia were reported, highlighting a significant public health concern. Amidst this backdrop, Pegfilgrastim, a medication essential for stimulating white blood cell production in patients undergoing […]